March 19, 2013 -- Get a first-hand introduction to EMD Millipore’s groundbreaking SmartFlare™ RNA Detection Probes at AACR. This novel reagent technology allows researchers to detect gene expression in live, intact cells - overcoming the limitations of lysed or fixed cell populations and yielding more physiologically relevant information. SmartFlare™ RNA detection probes offer:
• Identification of cell types and cell sorting based on RNA expression levels without transfection reagents or intrusive sample preparation
• A single incubation step using inert nanoparticle technology to specifically detect native RNA
• Ability to use the same cells in downstream assays
To schedule an interview appointment in advance of AACR, please contact: Leslie Eisenberg, Feinstein Kean Healthcare, leslie.eisenberg@fkhealth.com or (617) 244-3872.
Seminars on Live Cell RNA Detection: Booth #538
Benefits of analyzing RNA expression at the single cell level
Sunday, April 7, 1:00 PM
Monday April 8, 1:00 PM
Tuesday April 9, 10:00 AM
Wednesday April 10, 10:00 AM
Live cell miRNA detection
Sunday, April 7, 2:00 PM
Monday April 8, 2:00 PM
Sorting live cells based on RNA expression levels
Sunday, April 7, 3:00 PM
Monday April 8, 3:00 PM
Tuesday April 9, 11:00 AM
Wednesday April 10, 11:00 AM
Determining siRNA modulation of RNA levels in live cells
Sunday, April 7, 4:00 PM
Monday April 8, 4:00 PM
Exhibitor Spotlight Theater
Use of SmartFlare™ RNA Detection Probes enables live cell RNA detection and secreted miRNAs in serum
Tuesday, April 9, 12:30 PM
Speakers are available for interviews:
• Don Weldon, Research and Development Manager, EMD Millipore
• David Giljohann, Ph.D., Post-doctoral Fellow, Mirkin Research Group, Northwestern University
• Dominik Duelli, Ph.D., Assistant Professor, Rosalind Franklin University of Medicine and Science
About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany
